Actinic Keratosis Market: Industry Analysis, Epidemiology, Pipeline Therapies, Treatment and Companies by DelveInsight| Sandoz Pharmaceuticals, Bausch Health Companies, LEO Pharma, Almirall S.A., etc

July 07 04:43 2021
Actinic Keratosis Market: Industry Analysis, Epidemiology, Pipeline Therapies, Treatment and Companies by DelveInsight| Sandoz Pharmaceuticals, Bausch Health Companies, LEO Pharma, Almirall S.A., etc

Actinic Keratosis Market

Actinic keratosis is a chronic and prevalent disease affecting areas of sun-exposed skin where visible and subclinical, non-visible lesions coexist. This area of sun-damaged skin is prone to the development of further visible Actinic Keratosis lesions and sun-related skin cancer and is known as ‘field cancerization’. Actinic Keratosis lesions are being represented as small scaly patches that can be flat or slightly raised. Their color can range from one’s skin tone to a reddish-brown color. They differ in size from 3 mm to 10 mm across, and they may gradually enlarge. Actinic Keratosis lesions appear on areas which are most commonly exposed to sun, such as the face, scalp, shoulders, neck, the back of the hands and forearms, etc.


DelveInsight’s “Actinic Keratosis Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Actinic Keratosis , historical and forecasted epidemiology as well as the Actinic Keratosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.


Some key facts of Actinic Keratosis Report are:

  • Actinic Keratosis is more prevalent among male than female population. DelveInsight estimates that the male-to-female ratios of Actinic Keratosis patients differ among various countries, but a male excess is a consistent finding among all countries except Italy.
  • As per the estimation by DelveInsight’s analysts, the United States had the highest prevalence of Actinic Keratosis with approximately 66 million prevalent population in 2020.
  • Among the EU5 countries, Germany had the highest prevalent population with approximately 8 million cases followed by the United Kingdom with prevalent population of approximately 5 million in 2020. On the other hand, Japan has the lowest prevalent population with approximately 7 lakh Actinic keratosis cases in 2020.
  • Our analysis also suggests that due to the high prevalence of Actinic Keratosis and potential for lesions to become cancerous, maximum patients are treated.


Request for Free Sample Report:


Actinic Keratosis Symptoms

Actinic keratosis vary in appearance. Signs and symptoms include:

  • Rough, dry or scaly patch of skin, usually less than 1 inch (2.5 centimeters) in diameter
  • Flat to slightly raised patch or bump on the top layer of skin
  • In some cases, a hard, wartlike surface
  • Color variations, including pink, red or brown
  • Itching, burning, bleeding or crusting
  • New patches or bumps on sun-exposed areas of the head, neck, hands and forearms


Some of Actinic Keratosis Companies are:

  • Sandoz Pharmaceuticals
  • Bausch Health Companies (Formerly known as Valeant Pharmaceuticals)
  • LEO Pharma
  • Almirall S.A.
  • Aqua Pharmaceuticals
  • Biofrontera
  • Galderma
  • DUSA Pharmaceuticals
  • Photonamic GmbH & Co. KG
  • Almirall/Athenex
  • And Many Others


Actinic Keratosis therapies are:

  • Aldara
  • Zyclara
  • Solaraze
  • Efudex
  • Carac
  • Picato
  • Actikerell
  • Fluoroplex
  • Ameluz
  • Metvixia
  • Levulan Kerastick
  • Alacare
  • Klisyri (tirbanibulin)
  • And Many Others


Request for Free Sample Report:


Table of Contents:

1. Key Insights

2. Executive Summary of Actinic Keratosis

3. Competitive Intelligence Analysis for Actinic Keratosis

4. Actinic Keratosis : Market Overview at a Glance

5. Actinic Keratosis : Disease Background and Overview

6. Patient Journey

7. Actinic Keratosis Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Actinic Keratosis Treatment

11. Marketed Products

12. Emerging Therapies

13. Actinic Keratosis : Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Actinic Keratosis

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer


About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance.  Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States